CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 39 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $4,000 | -55.6% | 700 | -56.2% | 0.00% | – |
Q1 2018 | $9,000 | +50.0% | 1,600 | +40.0% | 0.00% | – |
Q4 2017 | $6,000 | -64.7% | 1,143 | -65.0% | 0.00% | – |
Q3 2017 | $17,000 | +183.3% | 3,268 | +195.2% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 1,107 | +10.1% | 0.00% | – |
Q1 2017 | $6,000 | +200.0% | 1,005 | +402.5% | 0.00% | – |
Q3 2013 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |